Abstract
From Dec. 1976 through June 1986, 474 patients with acute leukemia were treated with central nervous system (CNS) irradiation for the purpose of preventing relapse of CNS leukemia. Of the whole series, whole cranial irradiation at a dosage of 24 Gy and 4–5 intrathecal instillations of methotrexate (MTX) were given in 149 patients, simple intrathecal instillation of MTX in 44 patients and high dose intravenous MTX in 5 patients; the CNS relapse rates were 4.0%, 20.5% and 40.0% respectively. It was proved by our experience that whole cranial irradiation plus intrathecal MTX is the best approach to prevention of CNS leukemia relapses.
Similar content being viewed by others
References
Pinkel D, et al. Radiotherapy in leukemia and lymphoma of children. Cancer 1977; 39:817.
Dritschilo A, et al. The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia. Cancer 1976; 37:729.
伊 势泰.小児急性白血病の治療の現状. 日本 医事新報 1980;2591:26.
Aur R J, et al. Comparison of two methods of preventing central nervous system leukemia. Blood 1973; 42:349.
杨 士元, 等. 小儿急性白血病诊疗建议. 中华 儿科杂志 1987; 25:177.
多喜 纪雄,他.ALL患児CNS損傷の早期発現 と智能指数. 小児科臨床 1980;33:281.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shen, W., Han, P., Huang, S. et al. Central nervous system radiotherapy in acute leukemia. Chinese Journal of Cancer Research 1, 69–72 (1989). https://doi.org/10.1007/BF02684823
Issue Date:
DOI: https://doi.org/10.1007/BF02684823